A small dose of the magic mushroom-derived drug psilocybin along with psychotherapy can significantly reduce symptoms of severe depression in patients, according to a new study.
The research, published in the New England Journal of Medicine, assessed data from 233 participants with treatment-resistant depression in a clinical trial spanning 22 international sites across 10 countries in Europe and North America, including the Institute of Psychiatry, Psychology and Neuroscience (IoPPN) at King’s College, London.
